Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy

• Published in: Anticancer research Vol. 43; no. 1; pp. 223 - 230
• Main Authors: KUWADA, KAZUYA, KIKUCHI, SATORU, KURODA, SHINJI, YOSHIDA, RYUICHI, TAKAGI, KOSEI, NOMA, KAZUHIRO, NISHIZAKI, MASAHIKO, KAGAWA, SHUNSUKE, UMEDA, YUZO, FUJIWARA, TOSHIYOSHI
• Format: Journal Article
• Language: English
• Published: Greece International Institute of Anticancer Research 01.01.2023
• Subjects: Body weight; Body weight loss; Cancer; Chemotherapy; Comorbidity; Complications; Computed tomography; Dietary supplements; Frailty; Gastrectomy; Gastrectomy - adverse effects; Gastric cancer; Gastrointestinal surgery; Hospitals; Humans; Medical prognosis; Muscle, Skeletal - pathology; Musculoskeletal system; Patients; Postoperative; Postoperative Complications - etiology; Prognosis; Quality of life; Retrospective Studies; Risk Factors; Sarcopenia; Sarcopenia - complications; Sarcopenia - surgery; Skeletal muscle; Stomach Neoplasms - complications; Stomach Neoplasms - surgery; Surgery; Surgical outcomes; Survival; Tumors; Weight loss; skeletal muscle loss; gastrectomy; Gastric cancer; sarcopenia
• ISSN: 0250-7005; 1791-7530; 1791-7530
• DOI: 10.21873/anticanres.16153

It has recently been recognized that preoperative sarcopenia contributes to postoperative complications and overall survival in gastric cancer (GC). However, few studies have investigated the relationship between postoperative skeletal muscle loss (SML) and survival in GC, despite the inevitability of body weight loss after gastrectomy in most GC patients. Herein, we studied the impact of postoperative SML on GC prognosis. A total of 370 patients with GC who underwent curative gastrectomy were retrospectively evaluated in this study. Postoperative SML was assessed on computed tomography (CT) images taken before surgery and 1 year after surgery. The impact of postoperative SML on survival was evaluated. Postoperative severe SML was significantly associated with presence of comorbidities, higher tumor stage, higher postoperative complication rate and longer hospital stay. Univariate and multivariate analyses of prognostic factors for overall survival revealed that SML was an independent indicator of poor prognosis, along with age, tumor stage, preoperative sarcopenia, and operation time (hazard ratio, 2.65; 95% confidence interval, 1.68-4.20, p<0.0001). There was a strong association of severe postoperative SML with decreased overall survival in patients with preoperative sarcopenia. To improve the prognosis of GC patients after surgery, it is important to prevent postoperative SML as well as preoperative sarcopenia. Perioperative multimodal interventions including nutritional counseling, oral nutritional supplements, and exercise are required to prevent SML after gastrectomy.